Awareness, Risk Factors and Prevalence of Viral Hepatitis B and C among Antenatal Attendees in South-southern Nigeria: A Cross-sectional and Hospital-based Study

Victor Omote^1, , Henry Awele Ukwamedua², Nathaniel Bini¹, Johnson Etaghene³, Emmanuel Onome Omoviye⁴ and Mary Obiageli Iloka⁵

¹Department of Laboratory Services, Central Hospital Warri, Nigeria

²Department of Medical Laboratory Science, Faculty of Basic Medical Sciences, Ambrose Ali University, Ekpoma, Nigeria

³Department of Public Health, Ministry of Health Asaba, Delta state, Nigeria

⁴Department of Sales and logistics, ISN Products Nigeria Limited

⁵Department of Biomedical Analysis, IRGIB-AFRICA University, Republic of Benin

Cite this paper

Victor Omote, Henry Awele Ukwamedua, Nathaniel Bini, Johnson Etaghene, Emmanuel Onome Omoviye and Mary Obiageli Iloka. Awareness, Risk Factors and Prevalence of Viral Hepatitis B and C among Antenatal Attendees in South-southern Nigeria: A Cross-sectional and Hospital-based Study. American Journal of Public Health Research. 2020; 8(6):202-208. doi: 10.12691/AJPHR-8-6-4

Abstract

Background: Viral hepatitis was responsible for 1.34 million deaths globally in 2015, a number comparable to deaths caused by tuberculosis and higher than those caused by HIV. Although hepatitis B and C viral infections are major causes of liver cirrhosis or/and hepatocellular carcinoma, knowledge is limited and prevalence underestimated because of poor surveillance programs in most developing countries. Objectives: The aim of this study was to evaluate the level of awareness/knowledge, risk factors and prevalence of viral hepatitis B and C amongst antenatal attendees in a secondary health-care facility. Study design: The study was cross-sectional, descriptive and hospital-based. Methods: A total of 218 pregnant women were recruited from the antenatal clinic of Central Hospital Warri using simple random technique after approval from the institutional review board and consent from the participants. They were screened for Hepatitis B and C viral infections using a rapid immune-chromatographic test strip. Samples positive for HBsAg were screened for other HBV biomarkers using a 5 in one test cassette. Result: Of the 218 women screened, 3 (1.4%) were positive for HBsAg while 4 (1.8%) reacted for HCV antibodies. All positive cases for HBsAg were negative for HBeAg and HBsAb, but positive for HBeAb and HBcAb. Age-grade 31-40 gave the highest age-based prevalence 1.92% for HBsAg while participants younger than 20 years had the highest age-based prevalence of 20% (2/10) for HCV. Multiparous women had 2.8% for HBsAg while nulliparous/primiparous participants have the highest HCV antibody prevalence of 3.1%. For other variables measured, self-employed, Secondary school education, lack of HBV vaccination, women who share sharps and participants that engaged the services of quacks for invasive procedures gave the highest prevalence in their respective categories. Conclusion: The prevalence of 1.4% and 1.8% reported by this study for HBV and HCV respectively is relatively low when compared to a previous report for the study region and other Nigerian studies. However, the poor level of awareness/knowledge and high level of exposure to predisposing risk factors among the study population calls for urgent intervention if vision 2030 will be a reality for the study region.

Keywords

Hepatitis B and C, pregnant women, awareness, risk Factors, prevalence, Nigeria

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	World Health Organization (2017) Global Hepatitis Report, 2017. Geneva, Switzerland.
[2]	Ugbebor O, Aigbirior M, Osazuwa F, Enabudoso E, Zabayo O. (2011). The prevalence of hepatitis B and C viral infection among pregnant women. N Am J Med Sci; 3(5):238-41.
[3]	Omote V, Kashibu E, Ojumah I, Adda D, Etaghene J, Ukwamedua H. (2018). Serological screening of hepatitis B and C virus among patients attending a tertiary hospital in Jalingo, Taraba state, Nigeria. Saudi J. Health Sci; 7: 167-71.
[4]	McMahon BJ (2010). Natural History of chronic Hepatitis B. Clin Liver Dis; 14: 381-96.
[5]	Sangare L, Sombie R, Combassere AW, et al. (2009). Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, BurKina Faso. Bull Soc Pathol Exot; 102: 226-9.
[6]	Yelemkoure ET, Yonli AT, Montesano C, et al. (2018). Prevention of Mother-to-child-transmission of hepatitis B virus in Burkina Faso: screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns. J Public Health Afr; 9(3):816.
[7]	Surya IG, Komia K, Suwardewa TG, Mulyanto TF, Mishiro S. (2005). Serological markers of hepatitis B,C and E viruses and immune-deficiency virus type 1 infection in pregnant women in Bali, Indonesia. J Med Virol; 75(4):499-503
[8]	Onakenhor JU, Offor E, Okonosua FE. (2001). Maternal and neonatal sero-prevalence of hepatitis B surface antigen (HBsAg) in Benin city, Nigeria. J Obstet Gynaecol; 21(6): 583-6.
[9]	Ophori EA, Wagbasoma A, Atanunu O. (2004). Seroprevalence of Hepatitis B virus (HBV) among pregnant women in Central Hospital Warri, Delta state, Nigeria. J Microbiol; 18 (1-2): 217-22.
[10]	Kashibu E, Odoh C, Anye R, Omote V. (2017). Human immune-deficiency virus infection and hepatitis B virus co-infection: prevalence among pregnant women in jalingo, Taraba state, Nigeria. Asian J Pharm Hea Sci; 7(3):1665-9.
[11]	Aba HO, Aminu M. (2016). Seroprevalence of hepatitis B virus serological markers among pregnant Nigerian women. Ann Afr Med; 15(1): 20-7.
[12]	Ojule AC, Akani CL, Opurun HC, Ejilemele AA. (2005). Sero-prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Niger Postgrad Med J; 12: 260-70.
[13]	Ezegbudo CN, Agbonlahor DE, Nwobu GO, Igwe CN, Agba MI, Okpala HO. (2004). The seroprevalence of hepatitis B surface antigen and human immune-deficiency virus among pregnant women an Anambra state, Nigeria. Shiraz E med J. 5: 1-9.
[14]	Musa BM, Bussell S, Borodo MM, Samaila AA, Femi OL (2015). Prevalence of hepatitis B virus infection in Nigeria. 2000-2013: A systematic review and meta-analysis. Niger J Clin Pract; 18: 163-172.
[15]	Ezechi OC, Kalejaiye OO, Gab-okafor CV, Oladele DA, Oke BO et al. (2014). Seroprevalence and factors associated with hepatitis B and C co-infection in pregnant women living with HIV infection. Pan Afr Med J; 17:197
[16]	Oladeinde BH, Omoregie R, olley M, Anunibe JA, Oladeinde OB. (2012). Hepatitis B and C viral infections among pregnant women in a rural community of Nigeria. Inter J Bas App Virol; 1: 1-5.
[17]	Oti BV, Pennap GR, Ngari HR. (2018). HBsAg and anti-HCV prevalence among pregnant women accessing antenatal care in a Tertiary Health-care Facility in Central Nigeria. Heptol and Pancreat Sci; 2 (1):110.
[18]	Ebie JC, Pela OA. (2006). Some socio-cultural aspects of the problem of drug abuse in Nigeria. Drug ALC Dep; 8: 301-306.
[19]	Strickland GT. (2002). HCV in developing countries. Postgrad Doc (Africa); 24: 18-20.
[20]	Noubiap JJ, Nansseu JR, Ndoula SI, Bigna JJ, Jingi AM, Fokom-Domgore J. (2015). Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of far North Region of Cameroon. BMC Public Health; 15: 454.
[21]	Amsalu A, Ferede G, Eshetie S, Tadewos A, Assegu D. (2018). Prevalence, infectivity and associated risk factors of Hepatitis B virus among pregnant women in Yirgalem Hospital, Ethiopia: implication of screening to control Mother-to-child-transmission. J Preg. Article ID 8435910, 8 pages.
[22]	Anaedobe C, Fowotade A, Omoruyi C, Bakare R. (2015). Prevalence, socio-demographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwest Nigeria. Pan Afr Med J; 20:406.
[23]	Ali HS, Memon MA. (2007). Prevalence of Hepatitis B infection in pregnant women in a tertiary care hospital. Infect Dis J Pak; 2: 35-38.
[24]	Bittaye M, Idoko P, Ekele BA, Obed SA, Nyan O. (2019). Hepatitis B virus seroprevalence amongst pregnant women in the Gambia. BMC Infect Dis; 19: 259.
[25]	Onwuakor CE, Eze VC, Nwankwo IO, Iwu JO. (2014). Seroprevalence of Hepatitis B surface antigen (HBsAg) amongst pregnant women attending antenatal clinic at the Federal Medical Center Umuahia, Abia state. Nigeria. Am J Pub Hea Res; 2(6): 255-9.
[26]	Metaferia Y, Dessie W, Ali I, Amsalu A. (2016). Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in Southern Ethiopia: a hospital-based cross-sectional study. Epidemiology and Health; 38p.e 2016027.
[27]	Peto TJ, Mendy ME, Lowe Y, Webb EL, Whittle HC, Hall AJ. (2014). Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis intervention study (1986-90) and in the nationwide immunization program. BMC Infect Dis; 14:7.
[28]	Sani MM, Hafsat WI, Sakinatu MA, Ibrahim A, Sani M, Alhassan MY. (2018). Prevalence of hepatitis B viral infection at paediatric gastroenterology clinic of ABUTH, Zaria. Nig J Bas Clinc Sci; 15(2): 114-117.
[29]	Araoye, M.O. (2004) Sample Size Determination in Research Methodology with Statistics for Health and Social Sciences. Nathadex Publishers, Ilorin, 115-121.